Henry Wheeler | VP and Head of IR |
Mondher Mahjoubi | Chairman of Executive Board and CEO |
Joyson Karakunnel | Executive VP and Chief Medical Officer |
Yannis Morel | Executive VP of Product Portfolio Strategy and Business Development and Member of Executive Board |
Daina Graybosch | SVB Leerink |
Olga Smolentseva | Bryan Garnier |
Jingming Chen | Evercore |
Arthur He | H.C. Wainwright |
Good morning, everyone. My name is Juan, and I will be your conference operator today. At this time, I would like to welcome everyone to the Innate Pharma First Quarter 2022 Business Update. [Operator Instructions] I will now introduce to Mr. Henry Wheeler, Head of Investor Relations.